Literature DB >> 1927460

Neuro-otological manifestations in different stages of HIV infection.

R Hausler1, D Vibert, I J Koralnik, B Hirschel.   

Abstract

A systematic investigation of the incidence and type of peripheral and central auditory and vestibular disorders occurring in different stages of HIV infection was performed: 43 HIV-seropositive patients (14 were symptomatic with manifestation of AIDS or related complex and 29 were clinically asymptomatic) were compared with a matched control group of 33 HIV-seronegative homosexual volunteers. Among the symptomatic patients 8 (57%) out of 14 and among the asymptomatic HIV-positive patients, 13 (45%) out of 29 had abnormal results in various audiological, vestibular and electrophysiological tests. Only minor anomalies were found in 4 (12%) of the 33 seronegative homosexuals. Our results indicate a high incidence of neuro-otological disorders among patients suffering from AIDS. The numerous electrophysiological abnormalities found in asymptomatic HIV-seropositive persons suggest furthermore an early subclinical involvement of the auditory and vestibular systems.

Entities:  

Mesh:

Year:  1991        PMID: 1927460     DOI: 10.3109/00016489109131461

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  12 in total

1.  Vestibular function in HIV patients: preliminary report.

Authors:  R Teggi; L Giordano; V Pistorio; M Bussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-06       Impact factor: 2.124

Review 2.  High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patients.

Authors:  A P Riederer; G O Grein; J R Bogner
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

3.  Methamphetamine and lentivirus interactions: reciprocal enhancement of central nervous system disease.

Authors:  Salvador Huitron-Resendiz; Steven J Henriksen; Margaret C Barr; Maria P Testa; Elena Crawford; Loren H Parsons; Manuel Sanchez-Alavez; Tom R Phillips
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

4.  Static and dynamic posturography in patients with asymptomatic HIV-1 infection and AIDS.

Authors:  M Dellepiane; M C Medicina; R Mora; A Salami
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-12       Impact factor: 2.124

5.  Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys.

Authors:  O Prospéro-García; L H Gold; H S Fox; I Polis; G F Koob; F E Bloom; S J Henriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

7.  Using the zebrafish lateral line to screen for ototoxicity.

Authors:  Lynn L Chiu; Lisa L Cunningham; David W Raible; Edwin W Rubel; Henry C Ou
Journal:  J Assoc Res Otolaryngol       Date:  2008-04-12

8.  Vestibular Impairments on Objective Diagnostic Tests in HIV+ Women and Control Men and Women.

Authors:  Helen S Cohen; Michael W Plankey; Haleh Sangi-Haghpeykar
Journal:  Laryngoscope       Date:  2021-03-01       Impact factor: 3.325

9.  Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men.

Authors:  Helen S Cohen; Christopher Cox; Gayle Springer; Howard J Hoffman; Mary A Young; Joseph B Margolick; Michael W Plankey
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Audio-vestibular function in human immunodeficiency virus infected patients in India.

Authors:  Suma Susan Mathews; Rita Ruby Albert; Anand Job
Journal:  Indian J Sex Transm Dis AIDS       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.